We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy


MicroTissue: Transforming Drug Discovery

Industry Insight   Jan 30, 2018 | by Laura Elizabeth Mason, Science Writer, Technology Networks

MicroTissue: Transforming Drug Discovery

The StemoniX microHeart platform enables alignment of iPSC-derived cardiomyocytes to mimic the morphology and structure of heart cells, enabling improved assay outcomes for cardiac safety and efficacy drug studies. Credit: StemoniX

Laura Elizabeth Lansdowne

Senior Science Writer


Like what you just read? You can find similar content on the communities below.

Applied Sciences Cell Science Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free